MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, today announced the participation in the following industry events in September:
40th International Symposium on Intensive Care and Emergency Medicine
Location: Brussels, Belgium
Date: 31th August – 3d September, 2021
MedInvest General Life Science Conference
Date: 8 – 10th September, 2021
MedInvest presentation day: 8th September, 2021
For more upcoming events check “Events” page of the Company’s website at https://www.medisieve.com/News-Events/Events.
MediSieve is a biotech company, developing “Magnetic Blood Filtration”, a combination of a device and a therapeutic platform of treating blood-borne diseases by removing pathogens, toxins or other targets directly from a patient’s bloodstream. From sepsis to malaria to leukaemia and viral infections, such as COVID-19, MediSieve has the ambition of providing hospitals with a tool to tackle some of mankind’s most serious diseases.
INVESTOR AND PARTNERSHIP CONTACT:
MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
July 08, 2022
MediSieve at Industry Events In June 2022
June 29, 2022